摘要:
Pharmaceutical compositions containing a proanthocyanidin polymer composition which are useful for the treatment and prevention of secretory diarrhea are provided. The invention specifically relates to pharmaceutical formulations of a proanthocyanidin polymer composition which has been isolated from a Croton spp. or a Calophyllum spp. In particular, the invention relates to a formulation of a proanthocyanidin polymer composition which protects the composition from the effects of stomach acid after oral administration, particularly to those formulations which are enteric coated. The invention also relates to methods of producing a directly compressible proanthocyanidin polymer composition, as well as compositions containing the directly compressible proanthocyanidin polymer composition.
摘要:
A surgical device and method of making and using the same for implantation in a body of a mammal. One preferred device is prepared to include an elongated member. A region includes a pharmaceutical agent and a bioerodible material, a biodegradable material a bioavailable material or a mixture thereof.
摘要:
A time release orally administrable drug containing product comprising a core, a drug layer attached to the core, and first and second coating layers is disclosed. The first coating layer is directly adjacent to the drug layer, and has a limited permeability to water. The second coating layer is directly adjacent to the first coating, and is more permeable to water than the first layer. A method for using this drug in the treatment of a patient is also disclosed.
摘要:
The use of water-soluble or water-dispersible polyurethanes which consists ofa) 0.1-30% by weight of at least one polyol,b) 20-45% by weight of at least one polyetherpolyol,c) 10-45% by weight of at least one diamine comprising an ionic group,d) 30-50% by weight of at least one polyisocyanate with or withoute) further additives as coatings or binders for pharmaceutical presentations.
摘要:
A microcrystalline cellulose-based excipient having improved compressibility, whether utilized in direct compression, dry granulation or wet granulation formulations, is disclosed. The excipient is an agglomerate of microcrystalline cellulose particles and from about 0.1% to about 20% silicon dioxide particles, by weight of the microcrystalline cellulose, wherein the microcrystalline cellulose and silicon dioxide are in intimate association with each other. The silicon dioxide utilized in the novel excipient has a particle size from about 1 nanometer to about 100 microns. Most preferably, the silicon dioxide is a grade of colloidal silicon dioxide.
摘要:
Redispersible polymer powders or polymer granules consisting ofa) 10-95% by weight of polyvinyl acetate,b) 5-90% by weight of an N-vinylpyrrolidone-containing polymer,c) 0-20% by weight of another water-soluble or water-swellable substance andd) 0-20% by weight of a water-insoluble dusting agent with or withoute) other additives,are used as binders for producing solid pharmaceutical presentations, where the binder content in the presentation is from 0.5 to 20% by weight.
摘要:
The present invention is to a tablet formulation, being a medicament for oral administration for the treatment of bacterial infections, the tablet comprising a compacted mixture of 750-950 mg of amoxycillin and a quantity of clavulanate in a weight ratio of amoxycillin:clavulanate between 6:1 to 8:1 inclusive, and having a film coating of polymers which can be applied by aqueous film coating techniques.
摘要:
The use of redispersible polymer powders or polymer granules for coating pharmaceutical or agrochemical use forms, consisting ofa) 10-95% by weight of polyvinyl acetate,b) 5-90% by weight of an N-vinylpyrrolidone-containing polymer,c) 0-20% by weight of another water-soluble or water-swellable substance andd) 0-20% by weight of a water-insoluble dusting agent with or withoute) other additives.
摘要:
A controlled release tablet for oral administration is disclosed which has a tablet core including an insoluble therapeutically active agent having an aqueous solubility of less than or equal to about 5 mg/ml in a sufficient amount to render a therapeutic effect. The core provides rapid release of said therapeutically active agent upon exposure to aqueous solutions. The tablet core is coated with a controlled release coating permitting sustained release of said therapeutically active agent when said coated tablet is exposed to aqueous solutions.
摘要:
The invention relates to oral presentation forms for pantoprazole, which consist of a core, an intermediate layer and an outer layer which is resistant to gastric juice.